Evidence map›Paper›PMID 22554450›Full record

ReviewBritish journal of clinical pharmacology2013

Differences between opioids: pharmacological, experimental, clinical and economical perspectives.

Asbjørn M Drewes, Rasmus D Jensen, Lecia M Nielsen, Joanne Droney, Lona L Christrup, Lars Arendt-Nielsen, Julia Riley, Albert Dahan

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in British journal of clinical pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05639712 (Understanding Opioid Use Before and After Surgery in Norway), which is not on this map. Cited by 79 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05639712 phase4completednot on this mapstarted 2022, after this paper: background citation

Understanding Opioid Use Before and After Surgery in Norway: A Prospective Multicenter Study and Randomized Double-blind Controlled Study

TypeinterventionalSponsorOslo University HospitalRan2022 to 2025Enrolled1,020ConditionsOpioid Use, Affective SymptomsArmsPlacebo, Morphine 2.5 mg i.v., Morphine 5 mg i.v., Morphine 10 mg i.v., Oxycodone 2.5 mg i.v.
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 3 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.The Journal of pharmacology and experimental therapeutics · 2019
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Cancer pain.Nature reviews. Disease primers · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Asbjørn M DrewesMech-Sense, Department of Gastroenterology & Hepatology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark. amd@mech-sense.com
Rasmus D Jensen
Lecia M Nielsen
Joanne Droney
Lona L Christrup
Lars Arendt-Nielsen
Julia Riley
Albert Dahan
Aalborg University · DKRoyal Marsden Hospital · GBAalborg University Hospital · DKHealth Services and Performance Research Laboratory · FRLeiden University Medical Center · NLUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical studies comparing the response and side effects of various opioids have not been able to show robust differences between drugs. Hence, recommendations of the regulatory authorities have been driven by costs with a general tendency in many countries to restrict physician's use of opioids to morphine. Although this approach is recognized as cost-effective in most cases there is solid evidence that, on an individual patient basis, opioids are not all equal. Therefore it is important to have an armamentarium of strong analgesics in clinical practice to ensure a personalized approach in patients who do not respond to standard treatment. In this review we highlight differences between opioids in human studies from a pharmacological, experimental, clinical and health economics point of view. We provide evidence that individuals respond differently to opioids, and that general differences between classes of opioids exist. We recommend that this recognition is used to individualize treatment in difficult cases allowing physicians to have a wide range of treatment options. In the end this will reduce pain and side effects, leading to improved quality of life for the patient and reduce the exploding pain related costs.

Indexed as

Analgesics, OpioidAnimalsCost of IllnessDrug CostsHumansPainAnalgesics, Opioid

Identifiers

PMID22554450
PMCPMC3555047
OpenAlexW2115107257

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.